Status:
COMPLETED
Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity
Lead Sponsor:
Alexandria University
Conditions:
Osteopenia of Prematurity
Eligibility:
All Genders
1-2 years
Phase:
PHASE2
Brief Summary
In this study the effects of low and high doses of prophylactic vitamin D on biochemical and radiological manifestations of osetopenia of prematurity will be tested.
Detailed Description
The study will be conducted on (80) preterm infants that fulfill the eligibility criteria and delivered at Alexandria University Maternity Hospital (AUMH).
Eligibility Criteria
Inclusion
- Newborns with gestational age of ≤ 32 weeks and birth weight ≤ 1500 g.
Exclusion
- Newborns whose mothers were taking specific medications interacting with vitamin D metabolism (e.g., anticonvulsants, diuretics)
- Being NPO (nothing per oral) for more than 2 wks
- Gestational age more than 32 weeks
- Birth weight more than 1500 grams
Key Trial Info
Start Date :
August 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04768439
Start Date
August 10 2020
End Date
April 30 2021
Last Update
September 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
Alexandria, Egypt, 21131